tracking
Search Videos

Researcher spotlights changes in treatment of ALL
117 views | Added Dec 20, 2012 | Rate View top rated
Share this story
Email
Embed
ATLANTA — Matt Kalaycio, MD, director of the Bone Marrow Transplant Program at Taussig Cancer Institute at Cleveland Clinic, reacts to the findings of two studies that addressed the role of autologous vs. allogeneic transplantation in patients with acute lymphoblastic leukemia.
View more stories like this
home (1026)
Be the first to comment. Please sign in to add your thoughts below.
Related Videos
This collection is currently empty.